Track topics on Twitter Track topics that are important to you
Published with kind permission of MEDNOUS. AstraZeneca is raising its target for core earnings per share in 2011, but it expects that revenue will be flat or lower compared with 2010 as competition from generics and government healthcare reform exact a toll on sales. The forecast was issued with the company’s third-quarter results which [...]
Original Article: AstraZeneca raises its target for share earnings in 2011NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...